{"id":60640,"date":"2025-01-16T13:02:35","date_gmt":"2025-01-16T12:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/"},"modified":"2025-01-16T13:02:35","modified_gmt":"2025-01-16T12:02:35","slug":"kenvue-declares-quarterly-cash-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/","title":{"rendered":"Kenvue Declares Quarterly Cash Dividend"},"content":{"rendered":"
\n

SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue\u2019s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025.<\/p>\n

<\/a>
<\/a><\/p>\n

\nAbout Kenvue<\/span><\/b><\/p>\n

\nKenvue Inc. is the world\u2019s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno\u00ae<\/sup>, BAND-AID\u00ae<\/sup> Brand, Johnson\u2019s\u00ae<\/sup>, Listerine\u00ae<\/sup>, Neutrogena\u00ae<\/sup> and Tylenol\u00ae<\/sup>, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers\u2019 hands and earn a place in their hearts and homes. Learn more at www.kenvue.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Sofya Tsinis
\n
Kenvue_IR@Kenvue.com<\/a><\/p>\n

\nMedia Relations:<\/b>
Melissa Witt
\n
Media@Kenvue.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue\u2019s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025. About Kenvue Kenvue Inc. is the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-60640","format-standard","category-industry"],"yoast_head":"\nKenvue Declares Quarterly Cash Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kenvue Declares Quarterly Cash Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue\u2019s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025. About Kenvue Kenvue Inc. is the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-16T12:02:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250115060193\/en\/1778436\/22\/Kenvue_Logo_Black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Kenvue Declares Quarterly Cash Dividend\",\"datePublished\":\"2025-01-16T12:02:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/\"},\"wordCount\":155,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250115060193\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/\",\"name\":\"Kenvue Declares Quarterly Cash Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250115060193\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\",\"datePublished\":\"2025-01-16T12:02:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250115060193\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250115060193\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-declares-quarterly-cash-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kenvue Declares Quarterly Cash Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kenvue Declares Quarterly Cash Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Kenvue Declares Quarterly Cash Dividend - Pharma Trend","og_description":"SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue\u2019s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025. About Kenvue Kenvue Inc. is the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2025-01-16T12:02:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250115060193\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Kenvue Declares Quarterly Cash Dividend","datePublished":"2025-01-16T12:02:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/"},"wordCount":155,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250115060193\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/","url":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/","name":"Kenvue Declares Quarterly Cash Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250115060193\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","datePublished":"2025-01-16T12:02:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250115060193\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250115060193\/en\/1778436\/22\/Kenvue_Logo_Black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/kenvue-declares-quarterly-cash-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Kenvue Declares Quarterly Cash Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60640"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60640\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}